Get the app
US › Healthcare

YD Bio Ltd (YDES)

US · Healthcare · Biotechnology

$5.92-12.17%
Last close · 2026-10-16

Latest quarter · ended 2025-06-30

Net profit
$-2.2M
Profit YoY
-112.9%
EPS
$-0.65

Key statistics

Market cap
$476.7M
Forward P/E
0.0
P/B
51.15
Book value
$4.57
EPS (TTM)
$-0.04
52-week high
$22.00
52-week low
$1.70
50-day MA
$4.24
200-day MA
$5.99
Beta
-0.16

Shareholding

Insiders
80.18%
Institutions
0.40%

Largest institutional holders

FundStake
Garrett Wealth Advisory Group, LLC0.12%
Geode Capital Management, LLC0.09%
Cypress Capital Management, LLC0.05%
HPM Partners LLC0.05%
Citadel Advisors Llc0.04%
Jane Street Group LLC0.03%
UBS Group AG0.02%
Wolverine Asset Management LLC0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for YD Bio Ltd — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.